IIM
JAZZ icon

Ipswich Investment Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ipswich Investment Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-200
Closed -$30K – 237
2016
Q1 		$30K Buy
+200
New +$24.9K 0.01% 268

Other funds holding JAZZ

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ipswich Investment Management's JAZZ Position: Q2 2016 in Review

Ipswich Investment Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2016, closing a stake of 200 shares — an estimated $30K sold.

Ipswich Investment Management first reported a position in JAZZ in Q1 2016 and held it in 1 quarter. The position peaked at $30K in Q1 2016. 366 funds tracked by Wall St. Rank hold JAZZ as of Q2 2016.

  • Ipswich Investment Management reported no remaining Jazz Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Ipswich Investment Management sold 200 Jazz Pharmaceuticals shares in Q2 2016, an estimated $30K.
  • Ipswich Investment Management first reported a position in Jazz Pharmaceuticals in Q1 2016 and held it in 1 quarter.
  • Ipswich Investment Management's Jazz Pharmaceuticals position peaked at $30K in Q1 2016.
  • 366 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2016.

Based on Ipswich Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.